Patient P-02123
Synthetic patientMETA-24 · Day 166 · 35–44 · F · baseline S03Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
76%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S03
- Day 37 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 37.
Primary contributors, last 14 days
- Treatment adherence-11
- GI instability+10
- Inflammatory activity+10
- Toxicity-3
What helped?
No interventions yet.
LIFE OS recommendation
GI Support Protocol GI-04
65%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 89% showed improvement
- median effect visible after 8 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable7 min
improving · +0.3 vs previous 14 d
Sleep duration
Wearable6.2 h
stable · +0.1 vs previous 14 d
Energy level
Daily log2.6/10
improving · +0.5 vs previous 14 d
Steps
Wearable462
improving · +232 vs previous 14 d
GI burden
Companion73.4/100
improving · -5.9 vs previous 14 d
Adherence
Companion62.6 %
worsening · -10.1 vs previous 14 d
Sleep quality
Wearable38.2/100
improving · +1.6 vs previous 14 d
Glucose, CGM daily mean
CGM156 mg/dL
stable · -2.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 39 from the failing basin, 73 from restoration.
Would help
- GI-04 GI Support Protocol77% improved among 64 similar · onset 8 d · confidence 60%
- ME-01 Monitoring Escalation100% improved among 42 similar · onset 3 d · confidence 68%
- NP-02 Dietary Support Protocol59% improved among 32 similar · onset 10 d · confidence 68%
- More proteinGI -5.6 next day on high-intake days · n 18
Would not help
- Keep ultra-processed lowGI +6.1 next day on high-intake days · n 27
- Keep fat lowGI +4.7 next day on high-intake days · n 21
- Keep alcohol lowGI +4.7 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Ultra-processed food+6.1detractor · 95%
- Protein-5.6supporter · 95%
- Dietary fat load+4.7detractor · 95%
- Alcohol+4.7detractor · 95%
- Simple carbohydrates+4detractor · 95%
- Histamine load+3.9detractor · 95%
- Insoluble fibre+2no signal · 42%
- Caffeine-0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓65
- WearableResting HR 76 bpm
- Wearable462 steps/day
- WearableShort sleep window
- Butyrate / short-chain fatty acid production ↓55
- MicrobiomeButyrate capacity 30/100
- Daily logFibre intake low in recent food logs
- Mucosal barrier integrity ↓50
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Daily logGI symptom score 73 and rising
- Inflammatory signalling ↑50
- DNAIL6 -174 variant raises baseline inflammatory tone
- BloodInflammatory load index 66
- Drug metabolism and exposure ↑20
- BloodToxicity index 48
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 2.4 · butyrate capacity 30/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 51 ms
- Sleep
- 6.5 h
- Steps
- 803
- Resting HR
- 74 bpm
Daily log: GI score 73, nutritional resilience 36, adherence 63.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.